American investment firm Carlyle Group is planning to exit India’s SBI Life Insurance Company by offloading its remaining 1.9% stake.
The deal according to media reports could fetch around $289m for Carlyle Group.
The price range for the sale of shares has been set between $15.25 (INR1,130) and $15.34 (INR1,136.85).
As per the Economic Times’ report, Max Life Insurance Company, HDFC Standard Life Insurance, BNP Paribas Arbitrage, Bofa Securities Europe SA, Morgan Stanley Asia Singapore, Societe Generale and Integrated Core Strategies (Asia) are among the potential buyers of shares.
Carlyle Group had bought a 9% stake in SBI Life from BNP Paribas for approximately $776.22m in 2019.
Later that year it offloaded a 3% stake in the insurer for approximately $393.1m and in May this year, it sold a 4.2% stake.
In June this year, State Bank of India (SBI) announced the plans to sell a 2.1% stake in SBI Life Insurance through an offer for sale (OFS) to comply with the minimum public float requirement of 25%.
SBI Life is a joint venture between SBI and BNP Paribas Cardif. SBI now owns a stake of 55.5% in SBI Life and a 0.2% stake is held by BNP Paribas Cardiff.
Founded in 2001, SBI Life has a unique multi-distribution model encompassing bancassurance, retail agency, institutional alliance, and corporate solutions. It offers a range of life, health, pension, on-line and micro-insurance products.
